Porton News and Resources

Porton Pharma Solutions, a prominent CDMO, has announced a strategic partnership with Aojin to support the development of XDC conjugate drugs. This collaboration encompasses pharmaceutical CMC research and GMP production, with the goal of filing dual IND applications in China